|
Volumn 13, Issue , 2011, Pages
|
Towards new therapeutic approaches for malignant melanoma.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
SULFONAMIDE;
VEMURAFENIB;
ANIMAL;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
GENETICS;
HUMAN;
MELANOMA;
METABOLISM;
METASTASIS;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
REVIEW;
SKIN TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
HUMANS;
INDOLES;
MELANOMA;
MOLECULAR TARGETED THERAPY;
NEOPLASM METASTASIS;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
SKIN NEOPLASMS;
SULFONAMIDES;
MLCS;
MLOWN;
|
EID: 84857093928
PISSN: None
EISSN: 14623994
Source Type: Journal
DOI: 10.1017/s146239941100202x Document Type: Review |
Times cited : (44)
|
References (0)
|